Subscribe to our Newsletters !!

    Kumar Jeetendra

    AstraZeneca COVID-19 vaccine liable to ensure for a year: CEO

    AstraZeneca’s potential coronavirus immunization is probably going to give assurance against contracting COVID-19 for about a year, the organization’s CEO told a Belgian radio broadcast on Tuesday. The British drugmaker has just started human preliminaries of the antibody created by the University of Oxford, with a stage I preliminary in Britain because of end soon

    Alembic Pharma gains 6% on USFDA gesture for its iron tablet

    The portions of Alembic Pharmaceuticals picked up as much as 6 percent to Rs 943.80 on Tuesday. Prior today, the organization reported it had gotten last endorsement from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Deferasirox Tablets, 180 mg. The affirmed ANDA is remedially proportionate to the reference

    User-Friendly Support System for Laboratory Scale Reactions

    The ReactoMate DATUM from Asynt is a high quality, dual-rod stainless steel and aluminium support system built to ensure the stability and safety of your lab reactor. Sturdy, yet compact, the ReactoMate DATUM support system can accommodate a wide range of reaction vessels from 100 mL up to 5000 mL. Designed with user-friendliness in mind,

    Sanitizer formulations and Quality control

    Sanitizing is most important than anything to protect ourselves in this global pandemic situation. In this current Pandemic situation of COVID-19 it has made every one use hand sanitizer to get rid of any bit of virus present on our hands due to direct or indirect contact with infected one. According to WHO guidelines washing

    Researchers hail dexamethasone as ‘significant forward leap’ in rewarding coronavirus

    Dexamethasone, a modest and broadly utilized steroid, has become the primary medication demonstrated to have the option to spare lives among Covid-19 patients in what researchers hailed as a “significant forward leap”. Aftereffects of preliminaries reported on Tuesday demonstrated dexamethasone, which is utilized to decrease aggravation in different ailments, diminished demise rates by around a

    WHO sees ‘incredible news’ in steroid’s preliminary outcomes in COVID-19

    The World Health Organization (WHO) hailed as “incredible news” introductory clinical preliminary outcomes that demonstrated a modest and generally utilized steroid called dexamethasone can help spare the lives of fundamentally sick COVID-19 patients. “This is the primary treatment to be appeared to decrease mortality in patients with COVID-19 requiring oxygen or ventilator support,” WHO Director-General

    Serum Institute of India, UNICEF flexibly consent to give pneumonia immunization to low-income countries

    The Serum Institute of India will give ten million portions of the pneumococcal conjugate immunization, which assists with forestalling serious pneumonia, consistently to bring down salary nations for the following decade under another gracefully concurrence with the UNICEF that helped significantly diminished the cost of pneumonia antibody for those countries. “Pneumonia is the greatest single

    New Range of SARS-CoV-2 Spike Protein Products

    AMSBIO has launched a range of ready-to-use SARS-CoV-2 Spike protein coupled magnetic beads that combine convenience, minimum non-specific binding and developed operational protocols saving you time and hassle. Developed for immunocapture, cell stimulating, biopanning and flow cytometry applications these new products use biotinylated SARS-CoV-2 Spike protein pre-coupled to streptavidin conjugated magnetic beads, which can capture

    WHO ends preliminary of hydroxychloroquine in COVID-19 patients

    The World Health Organization said that testing of the intestinal sickness tranquilize hydroxychloroquine in its enormous multi-nation preliminary of medicines for COVID-19 patients had been stopped after outcomes from different preliminaries demonstrated no advantage. “The hydroxychloroquine arm of the SOLIDARITY preliminary has been halted,” WHO master Ana Maria Henao-Restrepo told a news instructions.

    Israel consents to arrangement with Moderna for potential COVID-19 antibody

    Israel has consented to an arrangement with Moderna Inc for the future acquisition of its potential COVID-19 antibody, Prime Minister Benjamin Netanyahu said on Wednesday. The Cambridge, Massachusetts-based biotech firm a week ago affirmed intends to begin a preliminary of 30,000 volunteers of its eagerly awaited immunization in July as the organization enters the last